Method for treatment of idiopathic inflammatory bowel disease (IIBD)
OwnerMichael McCann, Richard S. Abramsinventors
Life of this patent
Estimating the term…
Abstract
A new method for the prevention and treatment of Idiopathic inflammatory Bowel Disease (IIBD), including Crohn's Disease and Ulcerative Colitis, in human patients is provided. The key steps include sterilizing the intestinal tract with multiple antibiotics to kill the pre-existing bacterial flora, and replacing the latter with different, select, well-characterized bacteria taken from normal humans. The new microflora serve to generate more normal metabolic and immune responses, remitting thereby the IIBD.
Claims3
A method of preventing or treating idiopathic inflammatory bowel disease, Crohn's Disease or ulcerative colitis in a human patient comprising administering to said patient a composition comprising at least one antibiotic agent and at least one anti-fungal agent to sterilize the intestine of said patient and then infusing orally and rectally to said patient a specific bacteria composition to establish colonization of the intestine whereby the pathological immune response is normalized and inflammation ceases.
Dependencies are inferred from the claim text.